Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00883103 · ClinicalTrials.gov registry record · Phase 4
Double Blinded Randomized Trial Between Lidocaine And Plain Gel For Urethral Straight Catheterization And The Q-Tip Test
A Phase 4 study of Pain, sponsored by Baystate Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 137
- Enrollment target
- 1
- Study location
NCT00883103: Completed Phase 4 study of Pain, sponsored by Baystate Medical Center.
NCT00883103 is a Phase 4 study of Pain that has completed, run by Baystate Medical Center. The registered enrollment target is 137 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00883103, a Phase 4 study of Pain, has completed, sponsored by Baystate Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 137 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the pain perception between lidocaine and plain aqueous gel during assessment of postvoid residual volume and the Q-tip test.
Primary Outcome
A sterile catheter lubricated with the allocated gel was placed transurethrally into the bladder to measure the postvoid residual volume. After removal of the catheter, a cotton swab, coated with the same allocated gel, was advanced to the urethrovesical junction until resistance was felt. The angle of the swab with the horizontal plane was measured at rest and with a Valsalva maneuver. Immediately following the Q-tip test, the patient's perception of pain level was measured by Wong-Baker FACES
Conditions Studied
Interventions
- DRUG 2% Lidocaine jelly
- DRUG Plain aqueous gel
Study Locations (1)
Massachusetts
- Baystate Medical Center - Springfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2007-11 |
| Est. Completion | 2008-09 |
| Phase | Phase 4 |
What the finished NCT00883103 record still lists
NCT00883103 is an interventional study that assigns participants to a tested intervention. The registered 137 participants enrollment target is mid-sized for trials with a published cap, below the 304-participant average among 374 other Pain trials with a reported enrollment target (55% lower).
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which 2% Lidocaine jelly is the first listed.
NCT00883103 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00883103 about?
NCT00883103 is a clinical study titled "Double Blinded Randomized Trial Between Lidocaine And Plain Gel For Urethral Straight Catheterization And The Q-Tip Test". The purpose of this study is to compare the pain perception between lidocaine and plain aqueous gel during assessment of postvoid residual volume and the Q-tip test.
What is the current status of trial NCT00883103?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 137 participants. The study started on 2007-11. Estimated completion is 2008-09.
What conditions does trial NCT00883103 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT00883103?
The interventions under investigation include: 2% Lidocaine jelly (DRUG), Plain aqueous gel (DRUG).
Who is sponsoring clinical trial NCT00883103?
This trial is sponsored by Baystate Medical Center, which has 36 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00883103 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00883103's enrollment target sits among peer trials
137 124th of 374 higher than 251 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Magnesium on Neuromonitoring
RECRUITING · Phase 4
-
Low-Dose Ketamine Infusion During Burn Wound Care
RECRUITING · Phase 4
-
Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery
RECRUITING · Phase 4
-
Optimizing Pain Control in Transurethral Resection of the Prostate
RECRUITING · Phase 4
-
Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia
RECRUITING · Phase 4
-
Regional Blocks for Lateral Condyle Fractures
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05091424 · 137 participants · Phase 1
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
- NCT05655182 · 137 participants · Phase 1
A Study of BLB-201 RSV Vaccine in Infants and Children
- NCT06571669 · 137 participants · NA
BOOM-IBD2 Pivotal Clinical Trial
- NCT06644768 · 137 participants · Phase 1
A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia